Abstract

BackgroundIn heart failure (HF), evidence on the prognosis of simultaneously abnormal sodium and potassium levels remains unknown. Therefore, we investigated associations between sodium levels and 90-day all-cause mortality across potassium levels in HF patients. MethodsUsing Danish registers, we identified HF patients with sodium and potassium levels within 90 days following a redeemed loop diuretic prescription from 2000 to 2012. We grouped sodium (<139, 139–143, >143 mmol/L) and potassium levels (<3.5 [hypokalemia], 3.5–4.0, 4.1–4.6, 4.7–5.0, >5.0 mmol/L [hyperkalemia]). First, by adjusting for potassium groups using multivariable Cox regression, we compared mortality of sodium <139 mmol/L and >143 mmol/L with 139–143 mmol/L as reference. Second, by combining sodium and potassium groups, we compared mortality of the resulting 15 combinations using sodium 139–143 mmol/L and potassium 4.1–4.6 mmol/L as reference. ResultsWe included 16,343 HF patients (median age: 77.0 years; males: 53.7%). When adjusting for potassium groups, sodium <139 mmol/L and >143 mmol/L were associated with excess mortality (hazard ratio [HR]: 1.91, 95% confidence interval [CI]: 1.74–2.09; HR: 1.45, 95% CI: 1.25–1.68; respectively). When stratifying across potassium groups (interaction term: P = 0.291), we observed excess mortality with hyperkalemia for sodium <139 mmol/L (HR: 3.30, 95% CI: 2.76–3.96) and >143 mmol/L (HR: 3.46, 95% CI: 2.31–5.18), whereas mortality risk was lower for sodium 139–143 mmol/L (HR: 1.67, 95% CI: 1.30–2.14). Correspondingly, hypokalemia was associated with excess mortality (<139 mmol/L: HR: 3.53, 95% CI: 2.76–4.52; 139–143 mmol/L: HR: 2.47, 95% CI: 1.88–3.24; >143 mmol/L: HR: 2.67, 95% CI: 1.73–4.12). Lowest mortality risk appeared with sodium 139–143 mmol/L combined with remaining potassium groups. ConclusionAbnormal sodium is an important risk factor for mortality in HF patients receiving diuretics, and the importance is independent of potassium levels.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.